Credit Suisse Sticks to Its Buy Rating for DENTSPLY SIRONA (XRAY)

By Ryan Adsit

Credit Suisse analyst Erin Wright maintained a Buy rating on DENTSPLY SIRONA (XRAYResearch Report) on April 17 and set a price target of $50.00. The company’s shares closed last Friday at $40.86.

According to TipRanks.com, Wright is a 5-star analyst with an average return of 8.5% and a 62.4% success rate. Wright covers the Services sector, focusing on stocks such as Patterson Companies, AmerisourceBergen, and Medpace Holdings.

DENTSPLY SIRONA has an analyst consensus of Moderate Buy, with a price target consensus of $51.13, representing a 27.3% upside. In a report issued on April 2, Wolfe Research also upgraded the stock to Buy with a $66.00 price target.

See today’s analyst top recommended stocks >>

The company has a one-year high of $60.87 and a one-year low of $31.58. Currently, DENTSPLY SIRONA has an average volume of 2.53M.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

DENTSPLY SIRONA, Inc. engages in the design, manufacture, sales, and distribution of professional dental products and technologies. It operates through the Technologies and Equipment, and Consumables segments. The Technologies and Equipment segments comprises dental technology, equipment, and healthcare consumable products such as dental implants, laboratory dental products, computer-aided design and computer-aided manufacturing systems, imaging systems, treatment centers, and consumable medical device products. The Consumables segment offers preventive, restorative, instruments, endodontic, and orthodontic dental products. The company was founded in 2016 and is headquartered in York, PA.